血清素1A受体调节血清素2A受体介导的5 - 甲基-N,N-二甲基三胺类似物在小鼠中的行为效应
Grant C Glatfelter1, Allison A Clark2, Natalie G Cavalco2
1Designer Drug Research Unit, National Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, United States.
ACS chemical neuroscience
|December 5, 2024
概括
这项研究揭示了5-甲基-N,N-二甲基三胺 (5-MeO-DMT) 的类似物如何与血清素受体相互作用. 血清素1A (5-HT1A) 受体活性可以减少这些化合物的类似迷幻效应.
科学领域:
- 神经药理学神经药理学
- 心理药理学 心理药理学
- 药用化学 医学化学
背景情况:
- 5-甲基-N,N-二甲基三胺 (5-MeO-DMT) 的类似物正在探索其超出娱乐用途的治疗潜力.
- 了解这些化合物的神经药理学对于开发新药至关重要.
研究的目的:
- 为了确定5-MeO-DMT类似物体的体外受体简介.
- 描述了5-HT2A和5-HT1A受体中的功能活动.
- 为了检查5-HT1A在调节小鼠中5-HT2A介导的迷幻类效应中的作用.
主要方法:
- 在实验室中进行了受体结合和功能测试.
- 用小鼠头部抽反应 (HTR) 模型来评估类似迷幻药的效果.
- 研究了5-HT2A和5-HT1A受体的药理学对抗作用.
主要成果:
- 所有的5-MeO-DMT类似物都对多个点表现出很高的亲和力,包括5-HT2A和5-HT1A受体.
- 在小鼠中,化合物诱导了不同强度的HTRs,低温和低运动.
- 5-HT2A对抗性阻断了HTRs,而5-HT1A对抗性增强了它们,表明5-HT1A抑制了5-HT2A的影响.
结论:
- 阐明了5-MeO-DMT类别的迷幻效应的结构-活性关系.
- 5-HT1A激动剂在调节5-HT2A激动剂的急性精神活性作用方面发挥着重要作用.
- 这些发现为5MeO-DMT类似物的药物开发提供了关键的见解.
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
209
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
209
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
Drugs Affecting Neurotransmitter Release or Uptake
947
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
947
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
303
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
303
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146


